272 related articles for article (PubMed ID: 37231433)
21. Immune microenvironment of triple-negative breast cancer in African-American and Caucasian women.
O'Meara T; Safonov A; Casadevall D; Qing T; Silber A; Killelea B; Hatzis C; Pusztai L
Breast Cancer Res Treat; 2019 May; 175(1):247-259. PubMed ID: 30725384
[TBL] [Abstract][Full Text] [Related]
22. Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort.
Martini R; Chen Y; Jenkins BD; Elhussin IA; Cheng E; Hoda SA; Ginter PS; Hanover J; Zeidan RB; Oppong JK; Adjei EK; Jibril A; Chitale D; Bensenhaver JM; Awuah B; Bekele M; Abebe E; Kyei I; Aitpillah FS; Adinku MO; Ankomah K; Osei-Bonsu EB; Nathansan SD; Jackson L; Jiagge E; Petersen LF; Proctor E; Nikolinakos P; Gyan KK; Yates C; Kittles R; Newman LA; Davis MB
Sci Rep; 2021 Apr; 11(1):9247. PubMed ID: 33927264
[TBL] [Abstract][Full Text] [Related]
23. Comparative genomic analysis of PIK3R1-mutated and wild-type breast cancers.
Cobleigh MA; Layng KV; Mauer E; Mahon B; Hockenberry AJ; Abukhdeir AM
Breast Cancer Res Treat; 2024 Apr; 204(2):407-414. PubMed ID: 38153569
[TBL] [Abstract][Full Text] [Related]
24. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
Wang L; Zhai Q; Lu Q; Lee K; Zheng Q; Hong R; Wang S
Ann Med; 2021 Dec; 53(1):1358-1369. PubMed ID: 34396843
[TBL] [Abstract][Full Text] [Related]
25. Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.
Lehrberg A; Davis MB; Baidoun F; Petersen L; Susick L; Jenkins B; Chen Y; Ivanics T; Rakitin I; Bensenhaver J; Proctor E; Nathanson SD; Newman LA
Breast J; 2021 Jul; 27(7):573-580. PubMed ID: 33738890
[TBL] [Abstract][Full Text] [Related]
26. Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States.
Liede A; Sebby W; Miriyala AKR; Potluri R; Mazumder D; Ghosh A; Papademetriou E; Kilpatrick R; Tyczynski JE
BMC Cancer; 2023 Jan; 23(1):78. PubMed ID: 36690978
[TBL] [Abstract][Full Text] [Related]
27. Genomic, epigenomic, and transcriptomic signatures of prostate cancer between African American and European American patients.
Stevens C; Hightower A; Buxbaum SG; Falzarano SM; Rhie SK
Front Oncol; 2023; 13():1079037. PubMed ID: 36937425
[TBL] [Abstract][Full Text] [Related]
28. Enhanced immortalization,
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene X; 2020 Dec; 5():100030. PubMed ID: 32550556
[TBL] [Abstract][Full Text] [Related]
29. LXR/RXR pathway signaling associated with triple-negative breast cancer in African American women.
Torres-Luquis O; Madden K; N'dri NM; Berg R; Olopade OF; Ngwa W; Abuidris D; Mittal S; Lyn-Cook B; Mohammed SI
Breast Cancer (Dove Med Press); 2019; 11():1-12. PubMed ID: 30588086
[TBL] [Abstract][Full Text] [Related]
30. Single-Cell Transcriptome Analysis Revealed Heterogeneity and Identified Novel Therapeutic Targets for Breast Cancer Subtypes.
Vishnubalaji R; Alajez NM
Cells; 2023 Apr; 12(8):. PubMed ID: 37190091
[TBL] [Abstract][Full Text] [Related]
31. Multiethnic PDX models predict a possible immune signature associated with TNBC of African ancestry.
Jiagge EM; Ulintz PJ; Wong S; McDermott SP; Fossi SI; Suhan TK; Hoenerhoff MJ; Bensenhaver JM; Salem B; Dziubinski M; Oppong JK; Aitpillah F; Ishmael K; Osei-Bonsu E; Adjei E; Baffour A; Aldrich J; Kurdoglu A; Fernando K; Craig DW; Trent JM; Li J; Chitale D; Newman LA; Carpten JD; Wicha MS; Merajver SD
Breast Cancer Res Treat; 2021 Apr; 186(2):391-401. PubMed ID: 33576900
[TBL] [Abstract][Full Text] [Related]
32. Transcriptome profiling and network enrichment analyses identify subtype-specific therapeutic gene targets for breast cancer and their microRNA regulatory networks.
Elango R; Rashid S; Vishnubalaji R; Al-Sarraf R; Akhtar M; Ouararhni K; Decock J; Albagha OME; Alajez NM
Cell Death Dis; 2023 Jul; 14(7):415. PubMed ID: 37438342
[TBL] [Abstract][Full Text] [Related]
33. Differences in microRNA expression in breast cancer between women of African and European ancestry.
Gong Z; Wang J; Wang D; Buas MF; Ren X; Freudenheim JL; Belinsky SA; Liu S; Ambrosone CB; Higgins MJ
Carcinogenesis; 2019 Mar; 40(1):61-69. PubMed ID: 30321299
[TBL] [Abstract][Full Text] [Related]
34. Differences in the mutational landscape of triple-negative breast cancer in African Americans and Caucasians.
Ademuyiwa FO; Tao Y; Luo J; Weilbaecher K; Ma CX
Breast Cancer Res Treat; 2017 Feb; 161(3):491-499. PubMed ID: 27915434
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the genomic landscapes of Barbadian and Nigerian women with triple negative breast cancer.
Hercules SM; Liu X; Bassey-Archibong BBI; Skeete DHA; Smith Connell S; Daramola A; Banjo AA; Ebughe G; Agan T; Ekanem IO; Udosen J; Obiorah C; Ojule AC; Misauno MA; Dauda AM; Egbujo EC; Hercules JC; Ansari A; Brain I; MacColl C; Xu Y; Jin Y; Chang S; Carpten JD; Bédard A; Pond GR; Blenman KRM; Manojlovic Z; Daniel JM
Cancer Causes Control; 2022 Jun; 33(6):831-841. PubMed ID: 35384527
[TBL] [Abstract][Full Text] [Related]
36. Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.
Cherbal F; Gaceb H; Mehemmai C; Saiah I; Bakour R; Rouis AO; Boualga K; Benbrahim W; Mahfouf H
Breast Dis; 2015; 35(2):95-102. PubMed ID: 25736840
[TBL] [Abstract][Full Text] [Related]
37. Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer.
Sturtz LA; Melley J; Mamula K; Shriver CD; Ellsworth RE
BMC Cancer; 2014 Feb; 14():62. PubMed ID: 24495414
[TBL] [Abstract][Full Text] [Related]
38. Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations.
Davis M; Martini R; Newman L; Elemento O; White J; Verma A; Datta I; Adrianto I; Chen Y; Gardner K; Kim HG; Colomb WD; Eltoum IE; Frost AR; Grizzle WE; Sboner A; Manne U; Yates C
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414099
[TBL] [Abstract][Full Text] [Related]
39. Lower frequency of TLR9 variant associated with protection from breast cancer among African Americans.
Chandler MR; Keene KS; Tuomela JM; Forero-Torres A; Desmond R; Vuopala KS; Harris KW; Merner ND; Selander KS
PLoS One; 2017; 12(9):e0183832. PubMed ID: 28886076
[TBL] [Abstract][Full Text] [Related]
40. African Ancestry-Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent.
Martini R; Delpe P; Chu TR; Arora K; Lord B; Verma A; Bedi D; Karanam B; Elhussin I; Chen Y; Gebregzabher E; Oppong JK; Adjei EK; Jibril Suleiman A; Awuah B; Muleta MB; Abebe E; Kyei I; Aitpillah FS; Adinku MO; Ankomah K; Osei-Bonsu EB; Chitale DA; Bensenhaver JM; Nathanson DS; Jackson L; Petersen LF; Proctor E; Stonaker B; Gyan KK; Gibbs LD; Monojlovic Z; Kittles RA; White J; Yates CC; Manne U; Gardner K; Mongan N; Cheng E; Ginter P; Hoda S; Elemento O; Robine N; Sboner A; Carpten JD; Newman L; Davis MB
Cancer Discov; 2022 Nov; 12(11):2530-2551. PubMed ID: 36121736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
